Mr. Nielsen has served as a member of the board of directors of Apollo since 2012. Since 2001, Mr. Nielsen has been employed by Novo A/S, the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation, which manages the foundation’s financial assets through investments in the life science industry, where he currently serves as a Senior Partner. From 2006 to 2012, Mr. Nielsen was employed as a Partner at Novo Ventures (US) Inc. in San Francisco, a wholly-owned subsidiary of Novo A/S. He is a member of the board of directors of two publicly listed companies, Reata Pharmaceuticals Inc. and Merus N.V. Mr. Nielsen holds a M.Sc. in chemical engineering from the Technical University of Denmark and an M.S. in management of technology from the Technical University of Denmark. Apollo believes Mr. Nielsen’s qualifications to serve on the board of directors include his extensive experience in venture capital and medical technologies industry.